BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22162993)

  • 1. Pregnant women's access to PMTCT and ART services in South Africa and implications for universal antiretroviral treatment.
    Hussain A; Moodley D; Naidoo S; Esterhuizen TM
    PLoS One; 2011; 6(12):e27907. PubMed ID: 22162993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low rate of early vertical transmission of HIV supports the feasibility of effective implementation of the national PMTCT guidelines in routine practice of referral hospitals in Cameroon.
    Penda CI; Tejiokem MC; Sofeu CL; Ndiang ST; Ateba Ndongo F; Kfutwah A; Guemkam G; Warszawski J; Faye A; Study Group TA
    Paediatr Int Child Health; 2019 Aug; 39(3):208-215. PubMed ID: 31017537
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparing two service delivery models for the prevention of mother-to-child transmission (PMTCT) of HIV during transition from single-dose nevirapine to multi-drug antiretroviral regimens.
    Tsague L; Tsiouris FO; Carter RJ; Mugisha V; Tene G; Nyankesha E; Koblavi-Deme S; Mugwaneza P; Kayirangwa E; Sahabo R; Abrams EJ
    BMC Public Health; 2010 Dec; 10():753. PubMed ID: 21134259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.
    Maskew M; Jamieson L; Mohomi G; Long L; Mongwenyana C; Nyoni C; Mokaba D; Fox MP; Sanne I; Rosen S
    PLoS One; 2018; 13(8):e0201955. PubMed ID: 30161147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
    Omonaiye O; Kusljic S; Nicholson P; Manias E
    BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2016; 28 Suppl 1(sup1):114-8. PubMed ID: 26922939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study.
    van der Merwe K; Hoffman R; Black V; Chersich M; Coovadia A; Rees H
    J Int AIDS Soc; 2011 Aug; 14():42. PubMed ID: 21843356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delays, interruptions, and losses from prevention of mother-to-child transmission of HIV services during antenatal care in Johannesburg, South Africa: a cohort analysis.
    Schnippel K; Mongwenyana C; Long LC; Larson BA
    BMC Infect Dis; 2015 Feb; 15():46. PubMed ID: 25656597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'I fear my partner will abandon me': the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda.
    Alhassan Y; Twimukye A; Malaba T; Myer L; Waitt C; Lamorde M; Colbers A; Reynolds H; Khoo S; Taegtmeyer M
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):566. PubMed ID: 35840939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Zerbe A; le Roux DM; Kroon M; Myer L
    Lancet Child Adolesc Health; 2020 Mar; 4(3):220-231. PubMed ID: 31932246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coverage of highly active antiretroviral therapy among postpartum women in Malawi.
    Kumwenda J; Matchere F; Mataya R; Chen S; Mipando L; Li Q; Kumwenda NI; Taha TE
    Int J STD AIDS; 2011 Jul; 22(7):368-72. PubMed ID: 21729953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving care of HIV-infected pregnant women in Jamaica--from nevirapine to HAART.
    Johnson N; Palmer P; Samuels LA; Morgan O; Onyonyor A; Anderson M; Moore J; Billings C; Harvey KM; Mullings A; McDonald D; Alexander G; Smikle MF; Williams EW; Davis D; Christie CD
    West Indian Med J; 2008 Jun; 57(3):216-22. PubMed ID: 19583119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa.
    Moodley T; Moodley D; Sebitloane M; Maharaj N; Sartorius B
    BMC Pregnancy Childbirth; 2016 Feb; 16():35. PubMed ID: 26867536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from the PMTCT program in Swaziland: challenges with accepting lifelong ART for pregnant and lactating women - a qualitative study.
    Katirayi L; Chouraya C; Kudiabor K; Mahdi MA; Kieffer MP; Moland KM; Tylleskar T
    BMC Public Health; 2016 Oct; 16(1):1119. PubMed ID: 27776495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13.
    Hunt GM; Ledwaba J; Salimo A; Kalimashe M; Dinh TH; Jackson D; Sherman G; Puren A; Ngandu NK; Lombard C; Morris L; Goga A
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):787. PubMed ID: 31526373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of maternal mortality with highly active antiretroviral therapy in a large cohort of HIV-infected pregnant women in Malawi and Mozambique.
    Liotta G; Mancinelli S; Nielsen-Saines K; Gennaro E; Scarcella P; Magid NA; Germano P; Jere H; Guidotti G; Buonomo E; Ciccacci F; Palombi L; Marazzi MC
    PLoS One; 2013; 8(8):e71653. PubMed ID: 23990966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.